One of the biggest problems that new and small bulletins face is obtaining necessary information and reference materials, which are often too expensive for them to afford. If a bulletin can share resources and references with other drug bulletins or organizations, this can alleviate many of their difficulties in becoming established.
Lack of professional capacity and the scarcity of necessary materials invariably do not allow new bulletins to prepare all the in-depth review articles or original articles that they would like to produce. It helps them if they can use materials published by other drug bulletins, having first reached an agreement about this. (See Chapter 7 for more on sharing resources, and Chapter 11 on copyright.)
Exchange of documents that are difficult to obtain (for example, in the field of pharmacovigilance) among drug bulletins is always useful. Small and new or more experienced bulletins all face the same problems of lack of transparency, and difficult access to some data.